Board/Management Information • Jan 18, 2021
Board/Management Information
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 20106-2-2021 |
Data/Ora Ricezione 18 Gennaio 2021 17:56:28 |
MTA - Star | |
|---|---|---|---|
| Societa' | : | Pharmanutra S.p.A. | |
| Identificativo Informazione Regolamentata |
: | 141484 | |
| Nome utilizzatore | : | PHARMANUTRAN01 - Lacorte | |
| Tipologia | : | REGEM | |
| Data/Ora Ricezione | : | 18 Gennaio 2021 17:56:28 | |
| Data/Ora Inizio Diffusione presunta |
: | 18 Gennaio 2021 17:56:30 | |
| Oggetto | : | PR PHN - new advisory body 18_01_2021 | |
| Testo del comunicato |
Vedi allegato.
Pisa, 18th January 2021 - PharmaNutra S.p.A. (the "Company") communicates that the Board of Directors' meeting today has appointed a Supervisory Body pursuant to Legislative Decree 231/2001.
The Supervisory Body of the Company, with members Ms Rosa Annarumma (external member as Chairman), Mr Guido Carugi (Statutory Auditor) and Mr Pasquale Giovinazzo (Head of Internal Audit), will remain in office until approval of the financial statements for fiscal year 2022.
Founded and led by the President Andrea Lacorte and Vice President Roberto Lacorte, PharmaNutra was established in 2003. It develops unique nutritional supplements and innovative nutritional devices, handling the entire production process, from proprietary raw materials to finished product. The effectiveness of its products is documented by considerable scientific proof. The Group distributes and sells its products in Italy and abroad. In Italy, products are sold through a network of approximately 130 Pharmaceutical Representatives serving doctors and also exclusively selling PharmaNutra products to pharmacies throughout Italy. Products are sold in 50 countries abroad, through 32 partners selected from among the finest pharmaceutical companies. Over the years, PharmaNutra has stood out in the production of iron-based nutritional supplements with the trademark SiderAL®, where it can claim important Sucrosomial Technology® patents. The Group has developed a precise strategy for the management and production of intellectual property, founded on the integrated management of all the various elements: proprietary raw materials, patents, brands and clinical evidence.
For information:
Via Delle Lenze, 216/b - 56122 Pisa Tel. +39 050 7846500 [email protected]
Internal Press Office [email protected]
Via Santa Radegonda, 16 - 20121 Milan Tel. +39 02 83635708
Matteo Russo [email protected] Cristina Tronconi [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.